Edwards Lifesciences has earned FDA clearance for its blood flow monitoring platform.

Johnson & Johnson has acquired 3D-printing technology from Tissue Regeneration Systems.

Theranos promised CMS it will not run a lab for two years and settled to pay up $4.65 million to Arizona residents who had taken Theranos blood tests.

Boston Scientific has led a $23.1 million Series B investment in in heart failure firm NeuroTronik.

Cardinal Health will acquire Medtronic’s Patient Care, Deep Vein Thrombosis and Nutritional Insufficiency units for $6.1 billion in cash.

Bristol-Myers Squibb and Denmark’s Nordic Bioscience inked a deal to develop biomarker technology to diagnose and monitor nonalcoholic steatohepatitis.

Verily has unveiled its long-discussed wearable health tracker, Study Watch.

Massachusetts biotech Sentien has filed for approval to start clinical trials of a blood filtering device packed with bone marrow cells for severe cases of…

Medical Devices